Identification of small RNAs in Francisella tularensis
© Postic et al; licensee BioMed Central Ltd. 2010
Received: 19 July 2010
Accepted: 10 November 2010
Published: 10 November 2010
Regulation of bacterial gene expression by small RNAs (sRNAs) have proved to be important for many biological processes. Francisella tularensis is a highly pathogenic Gram-negative bacterium that causes the disease tularaemia in humans and animals. Relatively little is known about the regulatory networks existing in this organism that allows it to survive in a wide array of environments and no sRNA regulators have been identified so far.
We have used a combination of experimental assays and in silico prediction to identify sRNAs in F. tularensis strain LVS. Using a cDNA cloning and sequencing approach we have shown that F. tularensis expresses homologues of several sRNAs that are well-conserved among diverse bacteria. We have also discovered two abundant putative sRNAs that share no sequence similarity or conserved genomic context with any previously annotated regulatory transcripts. Deletion of either of these two loci led to significant changes in the expression of several mRNAs that likely include the cognate target(s) of these sRNAs. Deletion of these sRNAs did not, however, significantly alter F. tularensis growth under various stress conditions in vitro, its replication in murine cells, or its ability to induce disease in a mouse model of F. tularensis infection. We also conducted a genome-wide in silico search for intergenic loci that suggests F. tularensis encodes several other sRNAs in addition to the sRNAs found in our experimental screen.
Our findings suggest that F. tularensis encodes a significant number of non-coding regulatory RNAs, including members of well conserved families of structural and housekeeping RNAs and other poorly conserved transcripts that may have evolved more recently to help F. tularensis deal with the unique and diverse set of environments with which it must contend.
RNA regulators are important players in control of gene expression in bacteria and often mediate a response to changes in the environment (for review, see ). Some regulatory RNAs, designated riboswitches, are part of the mRNA they regulate. Riboswitches are sequences in the 5' end of mRNAs that change conformation upon binding of a ligand, affecting transcription or translation of the down-stream gene (positively or negatively). Other RNA regulators bind to proteins and regulate their function, whereas the largest group of small RNAs (sRNAs), act by base pairing with target RNAs. Base pairing sRNAs generally fall into two groups: cis-acting sRNAs that have capacity for extensive base pairing, and trans-encoded sRNAs with a more limited potential for base pairing with their target RNA. Trans-acting sRNAs regulate the translation and/or the stability of their target RNAs and each often regulate more than one target. For the most part, these sRNAs affect target genes in a negative fashion by binding to the region surrounding the start codon and ribosome binding site, but can act through base pairing in a region far upstream, and occasionally affect translation positively (for review see ). Many of the trans-encoded sRNAs require the RNA chaperone Hfq for function. Hfq promotes RNA-RNA interactions between the sRNA and its target mRNA and the protein may additionally stabilize the sRNA in vivo.
RNA regulators furthermore control pathogenesis in bacteria such as Staphylococcus aureus [2–6], Salmonella typhimurium [7–10], Vibrio cholerae [11–13], group A Streptococcus [14, 15], Pseudomonas aeruginosa [16–19], Clamydia trachomatis , and Clostridium perfringens [21, 22].
Francisella tularensis is a Gram-negative bacterium that causes the disease tularaemia in humans and in a large number of animals and is one of the most virulent bacterial pathogens known. The ability of F. tularensis to invade and replicate in host cells, particularly in immune cells such as macrophages, is critical for its capacity to cause disease. Once inside host cells, F. tularensis resides transiently inside a phagosome that matures into a late endosomal stage and the bacterium then escapes to replicate in the cytoplasm. The mechanism by which the bacterium escapes the phagosome is not well understood, but genes encoded in a pathogenicity island (FPI) are required for this step in the infectious cycle. Several regulatory proteins regulate virulence gene expression in F. tularensis by activating transcription of the FPI. These comprise the proteins MglA [23, 24], SspA , PrmA , and FevR (or PigR) [27, 28]. F. tularensis unlike many other bacteria encodes only one alternative sigma factor , no complete two component regulator pairs , and very little information exists concerning control of gene expression apart from the above mentioned regulation of the FPI.
We have recently studied the role of Hfq in the physiology and virulence of F. tularensis . Transcriptional analyses revealed that Hfq - directly or indirectly - regulates the expression of numerous genes in this pathogen. Functional studies showed that Hfq is required for stress resistance as well as for full virulence in both a fully virulent strain and in the attenuated live vaccine strain (LVS). Since Hfq normally performs its function by promoting sRNA-mRNA interactions, these results strongly suggest that sRNAs are expressed in this organism and are involved in diverse functions. Here, we have initiated the identification of the sRNAs expressed by F. tularensis LVS. We have assessed and identified the sRNA species that are expressed at high levels and found the commonly known 4.5S RNA, 5S rRNA, and the transfer messenger RNA (tmRNA). Additionally, we identified two novel sRNA species by cDNA cloning and have characterized these. Studies of sRNA mutant strains suggested potential targets for regulation. As an alternative approach to identify sRNAs in F. tularensis, we performed a bioinformatic prediction of sRNAs. Interestingly, this analysis found both the experimentally determined sRNA loci and additionally identified a number of other putative sRNA-containing intergenic regions.
Results and Discussion
Identification of highly expressed small RNA species of Francisella
Ten clones corresponding to RNA #4, the largest RNA, were sequenced and seven of these identified the RNA as the transfer messenger RNA (tmRNA; FTL_R001). This RNA is also designated SsrA and is 421 nt in size. tmRNAs are found in all bacteria and are highly expressed. The tmRNA has properties of both a tRNA and a mRNA. It participates in trans-translation, which is a reaction that transfers the translational complex to the tmRNA and ultimately leads to degradation of the polypeptide (for review, see ).
Based on the size of RNA #2, we presumed it was the 5S rRNA (114 nt). This was confirmed after cDNA sequencing. Next, RNA #1 was identified as the 4.5S RNA component of the signal recognition particle (FTL_R0044; 108 nt). FTL_R0044 was found in one of ten clones sequenced, whereas the other nine clones were the 5S rRNA. This is not very surprising considering the very similar size of these two transcripts and the high expression of the 5S RNA. Despite several attempts, we did not obtain any cDNA clones of RNA #3, the RNA with an apparent size of ~200 nt.
Cloning and identification of additional sRNAs
As our analysis of highly expressed RNA did not result in the identification of novel small RNA transcripts, we proceeded to construct a limited cDNA library of low molecular weight RNAs. For this, we used the same approach as described for the highly expressed sRNAs. Total RNA from bacteria grown under the different conditions described above, but depleted of ribosomal RNAs (16S and 23S rRNA), was separated on a 8% denaturing polyacrylamide gel and RNAs of approximately 100-200 nt were eluted from the gel and processed the same way as for the highly expressed RNAs. The gel was divided into smaller areas before eluting the RNAs and ten clones from each area (shown in Figure 1B) were sequenced in order to identify new sRNA species. By this method, we identified two different RNAs, one of which was identified twice from the same gel piece, whereas the remaining clones contained rRNA, tRNA or other contaminating sequences.
sRNA mapping, localization, and structure analysis
Small RNAs identified by cDNA cloning
> > <
> > >
To determine whether FtrA and FtrB are similar to known bacterial sRNAs, we performed BLAST to search the sequences of the non-coding RNA database http://ncrnadb.trna.ibch.poznan.pl/blast.html. No bacterial RNAs in the database showed sequence similarity to the two F. tularensis sRNAs. Sequences were also queried against the Rfam database http://rfam.sanger.ac.uk/, which did not result in any matches. Furthermore, a BLASTN search of the genes encoding either sRNA against the NCBI total sequence database showed that the genes are only found in Francisella and not in any other bacterial genome. This strongly indicates that the two RNAs are novel bacterial sRNAs.
Characterization of ftrA or ftrB mutants
To study the role of the sRNAs, we proceeded by creating mutant strains carrying a chromosomal deletion of either the ftrA or ftrB gene. Sequencing and Northern blotting were respectively used to confirm deletion of these loci and the absence of their corresponding transcripts (Figure 2). Neither mutant strain exhibited any growth defects or increased sensitivity to several stress conditions (H2O2, ethanol, low pH, NaCl; data not shown), showing that deleting either ftrA or ftrB does not affect the ability of F. tularensis to survive a number of stresses. Likewise, we did not observe any change in expression of either FtrA or FtrB after exposure to oxidative or osmolarity stress (data not shown).
To examine if FtrA or FtrB is required for virulence of F. tularensis, we assessed the ability of each mutant strain to induce disease in the mouse model of infection. No major difference in survival was observed between mice infected with wild-type LVS or with either of the mutant strains, showing that neither gene is required for virulence (data not shown). In addition, after infecting mice with a 1:1 mixture of mutant and wild-type bacteria we recovered equal numbers of wild-type and mutant bacteria from the spleen (data not shown). This further demonstrates that deleting ftrA or frtB does not affect F. tularensis pathogenicity in the mouse model.
It is important to recall that most sRNAs affect gene expression negatively. Deleting a specific sRNA gene and thus alleviating the repressive effect may not be of major consequence for the bacterium. Our results from in vitro characterization of the mutant strains therefore do not rule out the possibility that FtrA or FtrB may indeed control functions related to growth, stress resistance or virulence.
Identification of potential targets
Effect of ftrA and ftrB deletion on the transcriptome of LVS
Fold-change in ftrAb
Fold change in ftrBb
orotidine 5'-phosphate decarboxylase
YggT family protein
hypothetical membrane protein
anthranilate synthase component I
Identification of putative sRNAs using bioinformatics analysis
While our cloning based screen proved effective in identifying previously unknown sRNAs, the relatively small number of clones sequenced meant that only abundant small transcripts could be found using this approach. In an effort to identify putative sRNAs in F. tularensis that may have been missed in our physical screen, we used the bioinformatic tool SIPHT  to conduct a genome-wide bioinfomatic screen for candidate sRNAs in F. tularensis LVS. SIPHT identifies candidate intergenic loci based on the co-localization of intergenic conservation and Rho-independent terminators. It then annotates these candidates for several features, including the similarity of their primary sequence and predicted secondary structure to intergenic sequences in other bacterial replicons, their proximity to the putative binding sites of various transcription factors, and their homology to previously confirmed or predicted sRNAs and cis-regulatory RNA elements.
Putative sRNAs predicted in silicoa
52*, 32, 37
10*, 4, 24*, 2
19, 2, 2
9*, 4*, 7, 41, 7, 16*
8, 9, 13
11, 19, 24*
10, 13*, 2, 11
2*, 11, 12*, 20
12*, 2, 33*
Neither tmRNA nor 4.5S RNA were identified by SIPHT. Further analysis revealed that these loci were missed because they were not associated with predicted Rho-independent terminators. This may reflect a true paucity of Rho-independent terminators in F. tularensis or limitations in the ability of the three terminator predicting algorithms used by SIPHT to identify terminators in an AT rich genomes such as that of F. tularensis. The fact that these two sRNAs were not identified by SIPHT suggests that other F. tularensis sRNAs were likely missed in our screen.
Several characteristics of Francisella likely hinder predictions of sRNAs based on the proximity of intergenic sequence conservation and Rho-independent terminators. First, no genome sequences for close relatives of F. tularensis are available for BLAST comparisons and the relatively low GC content (32%) of the F. tularensis genome leads to spurious hits in BLAST searches that are more likely due to low sequence complexity than to actual sequence conservation. Second, as described above, it is also likely that existing terminator prediction programs, most of which had been trained on E. coli, are less effective in identifying terminators in AT-rich species such as Francisella. Indeed, in a kingdom-wide search for putative sRNAs in over 500 different strains, all Francisella sp. were among the 20 strains with the lowest density of putative intergenic Rho-independent terminators. However, while these factors likely contribute to both the decreased sensitivity and specificity of our sRNA predictions, the fact that both FtrA and FtrB were identified in our in silico screen suggests that the predictive algorithm used by SIPHT is effective in identifying novel sRNAs even in species such as Francisella that are AT-rich and have relatively few sequenced relatives.
Recently, a number of small ORFs encoding small peptides (<50 amino acids), previously non-annotated, have been identified in other bacterial species [37, 38]. We therefore examined whether the predicted sRNA loci in F. tularensis contain ORFs encoding small peptides (Table 3). A few loci could encode small peptides of 24-52 amino acids, but most loci contained none or only very short ORFs, further supporting the hypothesis that the majority of the loci encode putative RNAs.
Here, we have confirmed the expression in F. tularensis of the well-known non-coding RNAs tmRNA and 4.5S RNA after direct purification and cloning of the cDNAs. Two additional sRNAs expressed by F. tularensis were identified from a cDNA library prepared from low molecular weight RNA. The two putative sRNAs (called FtrA and FtrB), which are encoded in intergenic regions, were confirmed to be genuine sRNAs by Northern blot analysis and the transcripts were characterized with respect to transcription endpoints. The sRNAs do not show sequence similarity to any known sRNAs and their DNA sequences are only found in Francisella species, indicating that these are novel sRNAs. Deletion of either the ftrA or ftrB gene had no effect on bacterial survival during normal growth or stress, and did not affect the capacity of Francisella to induce disease in mice. This suggests that these sRNAs affect functions that are not required under the conditions tested or that additional sRNAs with redundant functions may exist. Specifically, in silico analysis identified conserved sequence between FtrB and sRNA candidate #20 (Table 3) suggesting they may be functional paralogues. Subsequently, microarray analysis allowed us to identify a number of potential targets of FtrA and FtrB regulation. Further experiments will be needed to verify if these represent real targets. Finally, in silico prediction of putative sRNA loci identified a number of Francisella IGRs, including the two harboring ftrA and ftrB. Future work will determine which of these IGRs indeed encode authentic sRNAs.
Bacterial growth and plasmids
Bacterial strains and plasmids
Strain or plasmid
Source or reference
subsp. holarctica, live vaccine strain
LVS with deletion of ftrA
LVS with deletion of ftrB
PCR cloning vector, KmR, AmpR
sacB suicide vector, KmR
pMP812 containing ~2 kb fragment for deletion of ftrA
pMP812 containing ~2 kb fragment for deletion of ftrB
Oligonucleotides used in this study
Sequence (5' to 3' direction)a
cDNA cloning and RACE
cDNA cloning and RACE
cDNA cloning and RACE
cDNA cloning and RACE
cDNA cloning tmRNA
cDNA cloning tmRNA
cDNA cloning tmRNA
cDNA cloning tmRNA
3' RACE ftrB
Verification of ftrA deletion
Verification of ftrA deletion
Verification of ftrA deletion
Verification of ftrA deletion
Verification of ftrB deletion
Verification of ftrB deletion
Verification of ftrB deletion
Verification of ftrB deletion
Bioinformatic prediction of sRNA loci
Candidate sRNAs were predicted using the SIPHT program, as described previously . Thresholds for BLAST E value, RNAMotif score, FindTerm score, and TransTerm confidence were set to 5e-3, -6, -10, and 86, respectively. All other parameters were set to default values.
Extraction of RNA for gel fractionation
LVS was grown to mid-exponential phase or to stationary phase in Schaedler-K3 before harvesting the bacteria. For oxidative stress experiments, bacteria at OD600 = 0.3 were exposed to 10 mM H2O2 for 30 min before harvested. For experiments at high osmolarity, LVS was grown in complex medium containing 2% NaCl to OD600 = 0.3 before being harvested. Total RNA was extracted using Trizol reagent (Invitrogen) according to the protocol provided by the manufacturer and treated with Turbo DNase (Ambion). For cDNA library construction, total RNA was depleted of 16S and 23S rRNAs using the MICROBExpress kit (Ambion) according to the protocol provided by the manufacturer before loaded on gel.
RNA elution and cDNA cloning
20 μg of total RNA was heated and loaded onto an 8% polyacrylamide/8M urea gel with the RNA Century Plus (Ambion) as size marker. After separation, the gel was stained with ethidium bromide and a gel piece containing RNA of a certain size was cut out. RNA was eluted from the gel after crushing and incubation at 37°C in 0.5 M ammonium acetate and 1 mM EDTA (pH 8.0) for 6 hours under constant agitation. Supernatants were extracted once with chloroform before precipitation of the RNA with isopropanol in the presence of glycogen. Next, 3' adapter was ligated to the dissolved RNA with T4 RNA ligase in the presence of DMSO and RNase inhibitor for 90 min at 37°C. The RNA was purified from a 15% polyacrylamide/urea gel as described above to remove non-incorporated adapters. The eluted RNA was treated with tobacco acid phosphatase (TAP) before ligation of 5' adapter (using the same method as for 3' adapters) and subsequently non-incorporated adapters removed by passing and twice washing the RNA on a Microcon YM-30 (Millipore) column. The RNA was reverse transcribed using the 3'PRIMER and SuperScript II reverse transcriptase (Invitrogen), PCR amplified using 5'PRIMER and 3'PRIMER and ligated into pCR2.1-TOPO. All RNAs were identified using this protocol, except the tmRNA for which we used a protocol that ligates the 3'adapter before the 5'adapter and utilizes different adapters (adapters B; see Table 5).
Total RNA was extracted using Trizol according to the manufacturer's instructions (Invitrogen) and quantified on a NanoDrop ND-1000 Spectrophotometer (Thermo Scientific). After extraction, 10 μg of total RNA were loaded on a polyacrylamide gel (8% acrylamide/8M urea). After migration, the RNA was transferred to a Hybond-N+ membrane (Amersham) and crosslinked with UV light. The membrane was prehybridized in Rapid-Hyb Buffer (Amersham). Then, 32P-labelled gene-specific probe (oligonucleotide, see Table 5) was added directly to the prehybridization buffer with the membrane and incubated for 16 hours at 42°C. After hybridization, the membrane was washed twice with 2×SSC/0.1% SDS, once with 1×SSC/0.1% SDS and twice with 0.1×SSC/0.1% SDS. Results were analyzed on a Storm 860 PhosphorImager (Molecular Dynamics) using the ImageQuant software (Molecular Dynamics).
5'- and 3'-RACE
For 5'-RACE, 15 μg of total RNA was incubated with TAP for 2 hours at 37°C after which 5' adapter was ligated with RNA ligase. RNA was purified from gel and reverse transcribed with a gene specific primer and SuperScript II RT. cDNA was then used as a template in PCR reaction with the 5'PRIMER and the gene specific primer (GSP_5'RACE) and cloned into pCR2.1-TOPO before sequencing.
3'-RACE was performed by ligating the 3' adapter to total RNA, followed by gel purification of adapter ligated RNA, reverse transcription with 3'PRIMER and finally conducting PCR with 3'PRIMER and GSP_3'RACE. The 3' end of each sRNA was determined by sequencing of cloned PCR products in pCR2.1-TOPO.
Construction of ftrA and ftrB mutants
Regions of approximately 1 kb upstream and downstream of ftrA and ftrB were amplified by PCR using primer pairs DelR/DelB and DelO/DelT. The upstream and downstream fragments were purified from gel, annealed and extended in 20 cycles of PCR without primers and the product further used as template in a PCR reaction with primers DelR and DelT. The ~2 kb PCR products were cloned into pCR2.1-TOPO (Invitrogen) and mobilized as a Not I-Sac I fragment into the sacB based suicide vector pMP812  creating pMP-ΔftrA and pMP-ΔftrB. pMP-ΔftrA and pMP-ΔftrB were introduced in LVS by electroporation and integration of the plasmid into the chromosome confirmed by PCR. Strains were then passed once in medium without selection, subsequently streaked on solid medium containing 6% sucrose and isolated colonies were tested for loss of the gene by PCR (using primer pairs DelCheck1/DelCheck4 and DelCheck2/DelCheck3). Deletion of the gene was confirmed by sequencing.
cDNA labeling and microarray hybridizations
RNA used in microarray experiments was extracted using Trizol reagent combined with purification of the aqueous phase on RNeasy columns (Qiagen). cDNA labeling and microarray hybridizations were performed as described . Three independent experiments and RNA extractions were performed and each set of RNAs was used in one hybridization experiment. The F. tularensis microarrays (obtained from the "Pathogen Functional Genomics Resource Center", PFGRC) contain 70-mer oligonucleotides, in five copies, representing all genes of strains SchuS4 and LVS. Microarrays were scanned with a Genepix 4000B scanner (Molecular Devices). To quantify signal fluorescence intensities, TIFF images were analyzed using the Genepix Pro 6.0 software. Statistical analyses were performed using publicly available software, the R/Bioconductor package LIMMA (available from http://www.bioconductor.org). A list of statistically significant differentially expressed genes was obtained using lowess normalization (after inspection of MA plots) and applying the empirical Bayes moderated t-test. Microarray data are available at ArrayExpress.
Quantitative real-time RT-PCR
To validate the microarray results, two ORFs were selected (for each mutant strain) for real-time quantitative reverse transcription PCR (qRT-PCR) analysis with the same RNA samples used in the microarray hybridizations. For the analyses, one microgram of RNA was reverse transcribed using random hexamers and SuperScript II reverse transcriptase (Invitrogen) according to the protocol provided by the manufacturer. Real-time PCR was performed with gene-specific primers using an ABI PRISM 7700 and FastStart SYBR master mix (Roche Diagnostics). To calculate the amount of gene-specific transcript, a standard curve was plotted for each primer set using a series of diluted genomic DNA from LVS. To compare the transcript amounts in the different strains, the amounts of each gene transcript was normalized to DNA helicase (FTL_1656) as this gene has been shown to change little in expression during growth . The expression of each gene was determined from three replicates in a single qRT-PCR experiment.
J774 cells were propagated in RPMI or Dulbecco's Modified Eagle's Medium (DMEM) medium containing 10% fetal calf serum. Cells were seeded at a concentration of ~2 × 105 cells per well in 12-well tissue plates (Falcon) and monolayers were used 24 hours after seeding. J774 macrophage monolayers were incubated for 90 min at 37°C with the bacterial suspensions (approximate multiplicities of infection 100) to allow the bacteria to enter. After washing (time zero of the kinetic analysis), the cells were incubated in fresh culture medium containing gentamicin (10 μg ml-1) to kill extracellular bacteria. At several time-points, cells were washed three times in PBS and processed for counting of surviving intracellular bacteria. For this, bacteria were recovered by lysis of macrophages with distilled water and the titer of viable bacteria released from the cells was determined by spreading preparations on agar plates. For each strain and time in an experiment, the assay was performed in triplicate. Each experiment was independently repeated two times and the data presented are from one experiment.
LVS and mutant strains were grown in Schaedler-K3 to exponential growth phase and diluted to the appropriate concentrations. 6 to 8-week-old female BALB/c mice (Janvier, Le Genest St Isle, France) were i.p. inoculated with 200 μl of bacterial suspension. Groups of five mice were inoculated with various doses of bacteria (approximately 101 to 104 bacteria) and the mortality was followed for 9 days. The actual number of viable bacteria in the inoculum was determined by plating dilutions of the bacterial suspension on chocolate plates. For competitive infections, LVS and mutant bacteria were mixed in 1:1 ratio and a total of approximately 400 bacteria were used for infection of five mice. After four days, mice were sacrificed. Homogenized spleen tissue from the five mice in one experiment were mixed, diluted and spread onto chocolate agar plates. PCR to distinguish wild-type and mutant bacteria were performed on 100 colonies. Animal experiments were performed according to the INSERM guidelines for laboratory animals' husbandry.
This work was funded by INSERM, CNRS and Université Paris Descartes.
We thank Dr. M. Pavelka for providing plasmid pMP812. DNA microarrays were obtained through NIAID's Pathogen Functional Resource Center, managed and funded by Division of Microbiology and Infectious Diseases, NIAID, NIH, DHHS and operated by The Institute for Genomic Research (TIGR).
- Waters LS, Storz G: Regulatory RNAs in bacteria. Cell. 2009, 136 (4): 615-628. 10.1016/j.cell.2009.01.043.PubMed CentralPubMedView Article
- Morfeldt E, Taylor D, von Gabain A, Arvidson S: Activation of alpha-toxin translation in Staphylococcus aureus by the trans-encoded antisense RNA, RNAIII. Embo J. 1995, 14 (18): 4569-4577.PubMed CentralPubMed
- Geisinger E, Adhikari RP, Jin R, Ross HF, Novick RP: Inhibition of rot translation by RNAIII, a key feature of agr function. Mol Microbiol. 2006, 61 (4): 1038-1048. 10.1111/j.1365-2958.2006.05292.x.PubMedView Article
- Boisset S, Geissmann T, Huntzinger E, Fechter P, Bendridi N, Possedko M, Chevalier C, Helfer AC, Benito Y, Jacquier A, et al: Staphylococcus aureus RNAIII coordinately represses the synthesis of virulence factors and the transcription regulator Rot by an antisense mechanism. Genes Dev. 2007, 21 (11): 1353-1366. 10.1101/gad.423507.PubMed CentralPubMedView Article
- Novick RP, Ross HF, Projan SJ, Kornblum J, Kreiswirth B, Moghazeh S: Synthesis of staphylococcal virulence factors is controlled by a regulatory RNA molecule. Embo J. 1993, 12 (10): 3967-3975.PubMed CentralPubMed
- Huntzinger E, Boisset S, Saveanu C, Benito Y, Geissmann T, Namane A, Lina G, Etienne J, Ehresmann B, Ehresmann C, et al: Staphylococcus aureus RNAIII and the endoribonuclease III coordinately regulate spa gene expression. Embo J. 2005, 24 (4): 824-835. 10.1038/sj.emboj.7600572.PubMed CentralPubMedView Article
- Padalon-Brauch G, Hershberg R, Elgrably-Weiss M, Baruch K, Rosenshine I, Margalit H, Altuvia S: Small RNAs encoded within genetic islands of Salmonella typhimurium show host-induced expression and role in virulence. Nucleic Acids Res. 2008, 36 (6): 1913-27. 10.1093/nar/gkn050.PubMed CentralPubMedView Article
- Julio SM, Heithoff DM, Mahan MJ: ssrA (tmRNA) plays a role in Salmonella enterica serovar Typhimurium pathogenesis. J Bacteriol. 2000, 182 (6): 1558-1563. 10.1128/JB.182.6.1558-1563.2000.PubMed CentralPubMedView Article
- Altier C, Suyemoto M, Ruiz AI, Burnham KD, Maurer R: Characterization of two novel regulatory genes affecting Salmonella invasion gene expression. Mol Microbiol. 2000, 35 (3): 635-646. 10.1046/j.1365-2958.2000.01734.x.PubMedView Article
- Santiviago CA, Reynolds MM, Porwollik S, Choi SH, Long F, Andrews-Polymenis HL, McClelland M: Analysis of pools of targeted Salmonella deletion mutants identifies novel genes affecting fitness during competitive infection in mice. PLoS Pathog. 2009, 5 (7): e1000477-10.1371/journal.ppat.1000477.PubMed CentralPubMedView Article
- Song T, Mika F, Lindmark B, Liu Z, Schild S, Bishop A, Zhu J, Camilli A, Johansson J, Vogel J, et al: A new Vibrio cholerae sRNA modulates colonization and affects release of outer membrane vesicles. Mol Microbiol. 2008, 70 (1): 100-111. 10.1111/j.1365-2958.2008.06392.x.PubMed CentralPubMedView Article
- Lenz DH, Miller MB, Zhu J, Kulkarni RV, Bassler BL: CsrA and three redundant small RNAs regulate quorum sensing in Vibrio cholerae. Mol Microbiol. 2005, 58 (4): 1186-1202. 10.1111/j.1365-2958.2005.04902.x.PubMedView Article
- Lenz DH, Mok KC, Lilley BN, Kulkarni RV, Wingreen NS, Bassler BL: The small RNA chaperone Hfq and multiple small RNAs control quorum sensing in Vibrio harveyi and Vibrio cholerae. Cell. 2004, 118 (1): 69-82. 10.1016/j.cell.2004.06.009.PubMedView Article
- Kreikemeyer B, Boyle MD, Buttaro BA, Heinemann M, Podbielski A: Group A streptococcal growth phase-associated virulence factor regulation by a novel operon (Fas) with homologies to two-component-type regulators requires a small RNA molecule. Mol Microbiol. 2001, 39 (2): 392-406. 10.1046/j.1365-2958.2001.02226.x.PubMedView Article
- Li Z, Sledjeski DD, Kreikemeyer B, Podbielski A, Boyle MD: Identification of pel, a Streptococcus pyogenes locus that affects both surface and secreted proteins. J Bacteriol. 1999, 181 (19): 6019-6027.PubMed CentralPubMed
- Heurlier K, Williams F, Heeb S, Dormond C, Pessi G, Singer D, Camara M, Williams P, Haas D: Positive control of swarming, rhamnolipid synthesis, and lipase production by the posttranscriptional RsmA/RsmZ system in Pseudomonas aeruginosa PAO1. J Bacteriol. 2004, 186 (10): 2936-2945. 10.1128/JB.186.10.2936-2945.2004.PubMed CentralPubMedView Article
- Ventre I, Goodman AL, Vallet-Gely I, Vasseur P, Soscia C, Molin S, Bleves S, Lazdunski A, Lory S, Filloux A: Multiple sensors control reciprocal expression of Pseudomonas aeruginosa regulatory RNA and virulence genes. Proc Natl Acad Sci USA. 2006, 103 (1): 171-176. 10.1073/pnas.0507407103.PubMed CentralPubMedView Article
- Burrowes E, Abbas A, O'Neill A, Adams C, O'Gara F: Characterisation of the regulatory RNA RsmB from Pseudomonas aeruginosa PAO1. Res Microbiol. 2005, 156 (1): 7-16. 10.1016/j.resmic.2004.07.004.PubMedView Article
- Bordi C, Lamy MC, Ventre I, Termine E, Hachani A, Fillet S, Roche B, Bleves S, Mejean V, Lazdunski A, et al: Regulatory RNAs and the HptB/RetS signalling pathways fine-tune Pseudomonas aeruginosa pathogenesis. Mol Microbiol. 2010, 76 (6): 1427-43. 10.1111/j.1365-2958.2010.07146.x.PubMed CentralPubMedView Article
- Grieshaber NA, Grieshaber SS, Fischer ER, Hackstadt T: A small RNA inhibits translation of the histone-like protein Hc1 in Chlamydia trachomatis. Mol Microbiol. 2006, 59 (2): 541-550. 10.1111/j.1365-2958.2005.04949.x.PubMedView Article
- Shimizu T, Yaguchi H, Ohtani K, Banu S, Hayashi H: Clostridial VirR/VirS regulon involves a regulatory RNA molecule for expression of toxins. Mol Microbiol. 2002, 43 (1): 257-265. 10.1046/j.1365-2958.2002.02743.x.PubMedView Article
- Ohtani K, Bhowmik SK, Hayashi H, Shimizu T: Identification of a novel locus that regulates expression of toxin genes in Clostridium perfringens. FEMS Microbiol Lett. 2002, 209 (1): 113-118. 10.1111/j.1574-6968.2002.tb11118.x.PubMedView Article
- Brotcke A, Weiss DS, Kim CC, Chain P, Malfatti S, Garcia E, Monack DM: Identification of MglA-regulated genes reveals novel virulence factors in Francisella tularensis. Infect Immun. 2006, 74 (12): 6642-6655. 10.1128/IAI.01250-06.PubMed CentralPubMedView Article
- Lauriano CM, Barker JR, Yoon SS, Nano FE, Arulanandam BP, Hassett DJ, Klose KE: MglA regulates transcription of virulence factors necessary for Francisella tularensis intraamoebae and intramacrophage survival. Proc Natl Acad Sci USA. 2004, 101 (12): 4246-4249. 10.1073/pnas.0307690101.PubMed CentralPubMedView Article
- Charity JC, Costante-Hamm MM, Balon EL, Boyd DH, Rubin EJ, Dove SL: Twin RNA polymerase-associated proteins control virulence gene expression in Francisella tularensis. PLoS Pathog. 2007, 3 (6): e84-10.1371/journal.ppat.0030084.PubMed CentralPubMedView Article
- Mohapatra NP, Soni S, Bell BL, Warren R, Ernst RK, Muszynski A, Carlson RW, Gunn JS: Identification of an Orphan Response Regulator Required for the Virulence of Francisella spp. and Transcription of Pathogenicity Island Genes. Infect Immun. 2007, 75 (7): 3305-3314. 10.1128/IAI.00351-07.PubMed CentralPubMedView Article
- Brotcke A, Monack DM: Identification of fevR, a novel regulator of virulence gene expression in Francisella novicida. Infect Immun. 2008, 76 (8): 3473-3480. 10.1128/IAI.00430-08.PubMed CentralPubMedView Article
- Charity JC, Blalock LT, Costante-Hamm MM, Kasper DL, Dove SL: Small molecule control of virulence gene expression in Francisella tularensis. PLoS Pathog. 2009, 5 (10): e1000641-10.1371/journal.ppat.1000641.PubMed CentralPubMedView Article
- Grall N, Livny J, Waldor M, Barel M, Charbit A, Meibom KL: Pivotal role of the Francisella tularensis heat-shock sigma factor RpoH. Microbiology. 2009, 155 (Pt 8): 2560-2572. 10.1099/mic.0.029058-0.PubMed CentralPubMedView Article
- Meibom KL, Forslund AL, Kuoppa K, Alkhuder K, Dubail I, Dupuis M, Forsberg A, Charbit A: Hfq, a novel pleiotropic regulator of virulence-associated genes in Francisella tularensis. Infect Immun. 2009, 77 (5): 1866-1880. 10.1128/IAI.01496-08.PubMed CentralPubMedView Article
- Pichon C, Felden B: Small RNA genes expressed from Staphylococcus aureus genomic and pathogenicity islands with specific expression among pathogenic strains. Proc Natl Acad Sci USA. 2005, 102 (40): 14249-14254. 10.1073/pnas.0503838102.PubMed CentralPubMedView Article
- Keiler KC: Biology of trans-translation. Annu Rev Microbiol. 2008, 62: 133-151. 10.1146/annurev.micro.62.081307.162948.PubMedView Article
- Markham NR, Zuker M: DINAMelt web server for nucleic acid melting prediction. Nucleic Acids Res. 2005, 33 (Web Server issue): W577-581. 10.1093/nar/gki591.PubMed CentralPubMedView Article
- Zuker M: Mfold web server for nucleic acid folding and hybridization prediction. Nucleic Acids Res. 2003, 31 (13): 3406-3415. 10.1093/nar/gkg595.PubMed CentralPubMedView Article
- Livny J, Teonadi H, Livny M, Waldor MK: High-throughput, kingdom-wide prediction and annotation of bacterial non-coding RNAs. PLoS One. 2008, 3 (9): e3197-10.1371/journal.pone.0003197.PubMed CentralPubMedView Article
- Rivas E, Eddy SR: Noncoding RNA gene detection using comparative sequence analysis. BMC Bioinformatics. 2001, 2: 8-10.1186/1471-2105-2-8.PubMed CentralPubMedView Article
- Hemm MR, Paul BJ, Schneider TD, Storz G, Rudd KE: Small membrane proteins found by comparative genomics and ribosome binding site models. Mol Microbiol. 2008, 70 (6): 1487-1501. 10.1111/j.1365-2958.2008.06495.x.PubMed CentralPubMedView Article
- Schmalisch M, Maiques E, Nikolov L, Camp AH, Chevreux B, Muffler A, Rodriguez S, Perkins J, Losick R: Small genes under sporulation control in the Bacillus subtilis genome. J Bacteriol. 2010, 192 (20): 5402-5412. 10.1128/JB.00534-10.PubMed CentralPubMedView Article
- Chamberlain RE: Evaluation of Live Tularemia Vaccine Prepared in a Chemically Defined Medium. Appl Microbiol. 1965, 13: 232-235.PubMed CentralPubMed
- LoVullo ED, Molins-Schneekloth CR, Schweizer HP, Pavelka MS: Single-copy chromosomal integration systems for Francisella tularensis. Microbiology. 2009, 155 (Pt 4): 1152-1163. 10.1099/mic.0.022491-0.PubMed CentralPubMedView Article
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.